Clinical Assessment
A thorough clinical assessment is essential for ME/CFS diagnosis, both to establish the presence of diagnostic criteria and to rule out alternative explanations for symptoms.
1 History Taking
1.1 Onset Characterization
The pattern of disease onset provides diagnostic and prognostic information:
Sudden Onset (60–80% of cases):
- Patient can identify exact date or event when illness began
- Most commonly follows acute infection: infectious mononucleosis (EBV), influenza, COVID-19, gastroenteritis
- May follow other physiological stressors: surgery, trauma, childbirth, vaccination
- Strong temporal association suggests post-infectious mechanism
- Diagnostic value: Sudden onset after documented infection strongly supports ME/CFS diagnosis
Gradual Onset (20–40% of cases):
- Symptoms develop over weeks to months without clear precipitant
- May follow period of chronic stress, cumulative sleep deprivation, or overwork
- Patient cannot identify specific triggering event
- Diagnostic challenge: Gradual onset requires more thorough differential diagnosis (autoimmune disease, occult malignancy, endocrine disorders)
1.2 Key Questions for Establishing Diagnosis
Post-Exertional Malaise Assessment:
- “After physical activity, do you feel worse than expected?”
- “Is there a delay between activity and symptom worsening? How long?” (Typical: 12–72 hours)
- “How long does it take to recover from doing too much?” (ME/CFS: days to weeks)
- “Can you reliably predict what activities will make you crash?”
- “Do mental tasks (reading, concentration) also trigger symptom flares?” (Cognitive PEM distinguishes ME/CFS from deconditioning)
Sleep Assessment:
- “Do you wake up feeling refreshed?” (ME/CFS: No, regardless of duration)
- “How many hours do you sleep?” (Rule out insufficient sleep)
- “Do you snore? Have you been told you stop breathing during sleep?” (Screen for obstructive sleep apnea)
- “What time do you go to sleep and wake up?” (Assess circadian rhythm disorders)
Cognitive Dysfunction:
- “Do you have trouble finding words or finishing sentences?”
- “Do you lose your train of thought mid-conversation?”
- “Can you read and retain information like you used to?”
- “Do you have difficulty with tasks that require sustained focus?”
- “Are these problems worse after physical or mental exertion?” (Cognitive PEM)
Orthostatic Symptoms:
- “Do you feel dizzy or lightheaded when standing up?”
- “Are showers or baths difficult? Do you need to sit?”
- “Do your symptoms worsen when standing for extended periods?”
- “Do you feel better when lying down?”
Functional Impact Assessment:
- “What percentage of your pre-illness activity level can you sustain now?”
- “What activities have you had to give up?” (Work, social activities, hobbies, childcare)
- “On a scale of 0–100 (Bell Disability Scale), what is your functional capacity?”
- “How many hours per week do you spend horizontal (lying down)?”
2 Physical Examination
2.1 Orthostatic Vital Signs
Orthostatic intolerance assessment should be performed on all ME/CFS patients:
Protocol:
- Patient supine for 5 minutes → measure heart rate (HR) and blood pressure (BP)
- Patient stands upright → measure HR and BP at 1, 3, 5, and 10 minutes
- Record symptoms during test (lightheadedness, nausea, cognitive impairment)
Abnormal Findings:
- Postural Orthostatic Tachycardia Syndrome (POTS): HR increase \(\geq 30\) bpm (or \(\geq 40\) bpm in adolescents) within 10 minutes of standing, without orthostatic hypotension
- Orthostatic Hypotension: Systolic BP decrease \(\geq 20\) mmHg or diastolic BP decrease \(\geq 10\) mmHg
- Neurally Mediated Hypotension (NMH): Delayed BP drop (after 5–10 minutes standing)
- Symptom reproduction: Patient reports typical symptoms even without meeting BP/HR criteria
Interpretation: 70–90% of ME/CFS patients demonstrate orthostatic intolerance on objective testing. Absence of objective findings does not exclude ME/CFS, but presence strongly supports the diagnosis and guides treatment (salt, fluids, fludrocortisone, midodrine). Note: an international expert consensus (Sivakoti et al. 2026) concludes the \(\geq 30\)/\(\geq 40\) bpm HR threshold is not reliably predictive of symptom burden and argues that a “non-POTS dysautonomia” population may fall below it; this recognition claim is consensus-based and not yet prospectively validated, so it supports clinical awareness but not loosening diagnostic discipline (see Do Not Withhold Nutritional Support Pending Psychiatric Diagnosis) (Sivakoti et al. 2026).
2.2 Neurological Examination
The neurological examination in ME/CFS typically shows:
Usually Normal:
- Cranial nerves intact
- Motor strength 5/5 (though patients report subjective weakness)
- Deep tendon reflexes normal
- No pathological reflexes (Babinski negative)
Potential Abnormalities:
- Cognitive testing: Impaired serial 7s, word recall, attention tasks
- Tandem gait or Romberg: May reveal subtle ataxia or balance impairment
- Sustained muscle testing: Rapid fatigability (e.g., handgrip dynamometer shows dramatic decline with repeated testing)
- Sensory testing: Hyperalgesia or allodynia in some patients (small fiber neuropathy)
Clinical Significance: The paucity of objective findings on standard neurological examination despite severe symptoms is characteristic of ME/CFS. This discordance (severe functional impairment with normal gross exam) historically led to dismissal of ME/CFS as “psychosomatic,” but advanced imaging and functional testing reveal objective abnormalities (cerebral blood flow reduction, autonomic dysfunction, immune activation). ### Tender Point Assessment
30–70% of ME/CFS patients meet criteria for fibromyalgia (widespread pain with tender points). Assessment:
- Digital palpation of 18 tender point sites with 4 kg pressure
- Fibromyalgia: \(\geq 11\) of 18 sites tender
- Presence of fibromyalgia does not exclude ME/CFS; these are frequently comorbid
- Guides pain management strategy
3 Laboratory Testing
3.1 Mandatory Exclusionary Testing
The following tests are required to rule out alternative diagnoses:
Hematology:
- Complete Blood Count (CBC): Rule out anemia, leukemia, lymphoma
- If anemia present: Iron studies, B12, folate
Chemistry:
- Comprehensive Metabolic Panel (CMP): Rule out renal failure, hepatic dysfunction, electrolyte disorders, diabetes
Endocrine:
- Thyroid function: TSH, free T4 (hypothyroidism is a common mimic)
- Consider: Morning cortisol, ACTH stimulation test if Addison disease suspected
Inflammation:
- Erythrocyte Sedimentation Rate (ESR) or C-Reactive Protein (CRP): Rule out active inflammatory disease
- Note: ESR/CRP are typically normal in ME/CFS, distinguishing it from autoimmune diseases
Autoimmune Screening:
- Antinuclear Antibody (ANA): Screen for lupus, Sjögren syndrome, other connective tissue diseases
- If ANA positive: Reflex to specific antibodies (anti-dsDNA, anti-Ro, anti-La)
Vitamins:
- Vitamin D: Deficiency is extremely common and contributes to fatigue
- Vitamin B12: Deficiency causes fatigue and cognitive impairment
Sleep Disorders:
- Polysomnography: Rule out obstructive sleep apnea (OSA) or upper airway resistance syndrome (UARS)
- OSA can fully mimic ME/CFS; CPAP treatment produces dramatic improvement in true OSA
- OSA and ME/CFS can coexist; treating comorbid OSA improves but does not cure ME/CFS
The characteristic laboratory finding in ME/CFS is that standard tests are normal:
- CBC: Normal (no anemia, normal WBC count)
- CMP: Normal (normal kidney, liver, electrolytes)
- TSH: Normal
- ESR/CRP: Normal or low-normal (distinguishes from inflammatory autoimmune diseases)
- ANA: Usually negative (or low-titer positive without clinical significance)
This pattern—severe functional disability with normal routine labs—is diagnostically significant. It distinguishes ME/CFS from conditions that present with obvious laboratory abnormalities. ### Advanced Biomarker Testing (If Available)
If resources permit, advanced testing can guide treatment:
Autoimmune Domain:
- GPCR autoantibody panel (\(\beta_2\)-adrenergic, M3/M4 muscarinic)
- NK cell count and cytotoxicity assay
- Flow cytometry for plasma cell populations (CD38+CD138+)
Metabolic Domain:
- Heng 7-biomarker panel (AMP, ADP, VWF, fibronectin, TSP-1, PDGF-BB, TGF-\(\beta\) 3) when commercially available
- Fasting lactate (elevated suggests mitochondrial dysfunction)
- ATP profile (specialized labs only)
Objective Functional Testing:
- Two-day cardiopulmonary exercise testing (CPET): Gold standard for documenting PEM
- Day 1 vs. Day 2 comparison shows failure to reproduce work capacity
- Reduction in VO2max, ventilatory threshold on Day 2 is diagnostic
Autonomic Testing:
- Formal tilt table testing (if orthostatic symptoms prominent)
- Heart rate variability analysis
- Quantitative sudomotor axon reflex test (QSART)
These tests are not required for diagnosis but enable Tier 2 biological phenotyping and treatment stratification.